Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
In the latest session, Rani Therapeutics Holdings Inc (NASDAQ: RANI) closed at $1.41 down -0.70% from its previous closing price of $1.42. In other words, the price has decreased by -$0.70 from its previous closing price. On the day, 0.69 million shares were traded. RANI stock price reached its highest trading level at $1.47 during the session, while it also had its lowest trading level at $1.35.
Ratios:
For a deeper understanding of Rani Therapeutics Holdings Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.60 and its Current Ratio is at 1.60. In the meantime, Its Debt-to-Equity ratio is 10.81 whereas as Long-Term Debt/Eq ratio is at 5.62.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on August 02, 2024, initiated with a Outperform rating and assigned the stock a target price of $17.
On June 14, 2024, Maxim Group started tracking the stock assigning a Buy rating and target price of $15.
On June 13, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $10.Rodman & Renshaw initiated its Buy rating on June 13, 2024, with a $10 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 13 ’24 when McKinley Kate bought 17,960 shares for $1.67 per share. The transaction valued at 29,993 led to the insider holds 17,960 shares of the business.
Imran Talat bought 10,296 shares of RANI for $19,974 on Dec 09 ’24. The Chief Executive Officer now owns 494,751 shares after completing the transaction at $1.94 per share. On Oct 15 ’24, another insider, South Cone Investments Limited, who serves as the 10% Owner of the company, sold 3,829,360 shares for $2.65 each. As a result, the insider received 10,141,674 and left with 8,302,194 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RANI now has a Market Capitalization of 82556064 and an Enterprise Value of 75893648.
Stock Price History:
The Beta on a monthly basis for RANI is 0.16, which has changed by -0.57293236 over the last 52 weeks, in comparison to a change of 0.21313763 over the same period for the S&P500. Over the past 52 weeks, RANI has reached a high of $8.75, while it has fallen to a 52-week low of $1.24. The 50-Day Moving Average of the stock is -7.79%, while the 200-Day Moving Average is calculated to be -52.17%.
Shares Statistics:
For the past three months, RANI has traded an average of 1.03M shares per day and 3814120 over the past ten days. A total of 29.81M shares are outstanding, with a floating share count of 22.81M. Insiders hold about 31.51% of the company’s shares, while institutions hold 14.71% stake in the company. Shares short for RANI as of 1730332800 were 1491169 with a Short Ratio of 1.95, compared to 1727654400 on 788592. Therefore, it implies a Short% of Shares Outstanding of 1491169 and a Short% of Float of 7.7199996.
